New booster study shows promise for COVID-19 protection
NCT ID NCT05542862
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study looked at whether the SpikoGen vaccine works well as a booster (3rd or 4th dose) for adults who already had a COVID-19 vaccine. 81 adults received one shot, and researchers measured their immune response and any side effects. The goal was to see if SpikoGen could boost protection against COVID-19 regardless of which vaccine people had first.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARASMI
Adelaide, South Australia, 5042, Australia
Conditions
Explore the condition pages connected to this study.